289 related articles for article (PubMed ID: 37554308)
1. Functional genomics in stem cell models: considerations and applications.
Shevade K; Peddada S; Mader K; Przybyla L
Front Cell Dev Biol; 2023; 11():1236553. PubMed ID: 37554308
[TBL] [Abstract][Full Text] [Related]
2. Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies.
McTague A; Rossignoli G; Ferrini A; Barral S; Kurian MA
Front Genome Ed; 2021; 3():630600. PubMed ID: 34713254
[TBL] [Abstract][Full Text] [Related]
3. Gene Modulation with CRISPR-based Tools in Human iPSC-Cardiomyocytes.
Han JL; Entcheva E
Stem Cell Rev Rep; 2023 May; 19(4):886-905. PubMed ID: 36656467
[TBL] [Abstract][Full Text] [Related]
4. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
Zhang Y; Sastre D; Wang F
Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-based functional genomics for neurological disease.
Kampmann M
Nat Rev Neurol; 2020 Sep; 16(9):465-480. PubMed ID: 32641861
[TBL] [Abstract][Full Text] [Related]
7. CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived Neurons.
Tian R; Gachechiladze MA; Ludwig CH; Laurie MT; Hong JY; Nathaniel D; Prabhu AV; Fernandopulle MS; Patel R; Abshari M; Ward ME; Kampmann M
Neuron; 2019 Oct; 104(2):239-255.e12. PubMed ID: 31422865
[TBL] [Abstract][Full Text] [Related]
8. CRISPRi: a way to integrate iPSC-derived neuronal models.
Franks SNJ; Heon-Roberts R; Ryan BJ
Biochem Soc Trans; 2024 Apr; 52(2):539-551. PubMed ID: 38526223
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9 facilitates genomic editing for large-scale functional studies in pluripotent stem cell cultures.
Li XF; Zhou YW; Cai PF; Fu WC; Wang JH; Chen JY; Yang QN
Hum Genet; 2019 Dec; 138(11-12):1217-1225. PubMed ID: 31606751
[TBL] [Abstract][Full Text] [Related]
10. Genome Editing of Induced Pluripotent Stem Cells Using CRISPR/Cas9 Ribonucleoprotein Complexes to Model Genetic Ocular Diseases.
Getachew H; Chinchilla B; Fernandez-Godino R
Methods Mol Biol; 2022; 2549():321-334. PubMed ID: 34128206
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-based functional genomics screening in human-pluripotent-stem-cell-derived cell types.
Li K; Ouyang M; Zhan J; Tian R
Cell Genom; 2023 May; 3(5):100300. PubMed ID: 37228745
[TBL] [Abstract][Full Text] [Related]
12. Precision Modulation of Neurodegenerative Disease-Related Gene Expression in Human iPSC-Derived Neurons.
Heman-Ackah SM; Bassett AR; Wood MJ
Sci Rep; 2016 Jun; 6():28420. PubMed ID: 27341390
[TBL] [Abstract][Full Text] [Related]
13. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.
Itoh M; Kawagoe S; Tamai K; Nakagawa H; Asahina A; Okano HJ
J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9 Genome Editing of Human-Induced Pluripotent Stem Cells Followed by Granulocytic Differentiation.
Dannenmann B; Nasri M; Welte K; Skokowa J
Methods Mol Biol; 2020; 2115():471-483. PubMed ID: 32006418
[TBL] [Abstract][Full Text] [Related]
15. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
[TBL] [Abstract][Full Text] [Related]
16. Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9.
Ben Jehuda R; Shemer Y; Binah O
Stem Cell Rev Rep; 2018 Jun; 14(3):323-336. PubMed ID: 29623532
[TBL] [Abstract][Full Text] [Related]
17. Correction of Hirschsprung-Associated Mutations in Human Induced Pluripotent Stem Cells Via Clustered Regularly Interspaced Short Palindromic Repeats/Cas9, Restores Neural Crest Cell Function.
Lai FP; Lau ST; Wong JK; Gui H; Wang RX; Zhou T; Lai WH; Tse HF; Tam PK; Garcia-Barcelo MM; Ngan ES
Gastroenterology; 2017 Jul; 153(1):139-153.e8. PubMed ID: 28342760
[TBL] [Abstract][Full Text] [Related]
18. CRISPR Interference Efficiently Induces Specific and Reversible Gene Silencing in Human iPSCs.
Mandegar MA; Huebsch N; Frolov EB; Shin E; Truong A; Olvera MP; Chan AH; Miyaoka Y; Holmes K; Spencer CI; Judge LM; Gordon DE; Eskildsen TV; Villalta JE; Horlbeck MA; Gilbert LA; Krogan NJ; Sheikh SP; Weissman JS; Qi LS; So PL; Conklin BR
Cell Stem Cell; 2016 Apr; 18(4):541-53. PubMed ID: 26971820
[TBL] [Abstract][Full Text] [Related]
19. New Developments in CRISPR/Cas-based Functional Genomics and their Implications for Research Using Zebrafish.
Prykhozhij SV; Caceres L; Berman JN
Curr Gene Ther; 2017; 17(4):286-300. PubMed ID: 29173171
[TBL] [Abstract][Full Text] [Related]
20. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
